Blood Type May Predict Risk of Venous Thromboembolism Among Patients With Cancer
Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.
Diagnosis & Disease Information
Apixaban Compared With Dalteparin in Cancer-Related Venous Thromboembolism
Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.
Large PICC Size May Up Risk for Thrombosis in Cancer Patients
Risk for thrombosis doubled if catheter-to-vein ratio exceeds 45 percent for peripherally inserted central catheter
Pharmacomechanical Thrombolysis for Acute DVT Tied to Kidney Injury
Bilateral deep vein thrombosis, single-session treatment, and female sex tied to greater risk
Anemia May Increase Risks of Ischemic Stroke and Poststroke Mortality
Researchers sought to determine whether patients with anemia had an increased risk of ischemic stroke and poststroke mortality.
High Incidence of Thrombotic Complications, Lower Mortality in the Second Wave of Patients With COVID-19
Researchers sought to assess the incidence of thrombotic complications in the second wave of patients with COVID-19, how many patients had diagnostic imaging for these complications, overall mortality, and then compared these outcomes with the first wave.
Moderate to Severe CKD Shown to Worsen VTE Prognosis
In a study, patients with moderate to severe CKD vs mild or no CKD had increased risk for death and recurrent venous thromboembolism.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...